Saveo Healthtech raises over Rs 36 crore in funding round

The company plans to utilise the capital to widen its reach in existing geographies as well as enter new geographies by establishing new hubs and building a full-stack tech platform.

Published On 2022-09-29 03:30 GMT   |   Update On 2022-09-29 08:37 GMT

Mumbai: Pharma marketplace Saveo Healthtech on Wednesday said it raised USD 4.5 million in a funding round co-led by Matrix Partners, Gunosy Capital, and 4Point Health Ventures.The latest round also saw participation from existing investors LC Nueva, Jetty Ventures, Ocgrow Ventures, Capier Investments, RTP Global, India Quotient, and Incubate Fund, the startup said in a statement.With this,...

Login or Register to read the full article

Mumbai: Pharma marketplace Saveo Healthtech on Wednesday said it raised USD 4.5 million in a funding round co-led by Matrix Partners, Gunosy Capital, and 4Point Health Ventures.

The latest round also saw participation from existing investors LC Nueva, Jetty Ventures, Ocgrow Ventures, Capier Investments, RTP Global, India Quotient, and Incubate Fund, the startup said in a statement.

With this, the three-year-old startup has mopped up USD 13 million so far. It had raised USD 4 million in seed round in January 2021 and USD 4.5 million in January this year.

The company plans to utilise the capital to widen its reach in existing geographies as well as enter new geographies by establishing new hubs and building a full-stack tech platform.

Read also: Yatharth Hospital gets SEBI green signal to launch Rs 610 crore IPO

Founded by IIT graduates Amit Kumar, Anurag Savarnya, Shivansh Shrivastava, and Vivek Jaiswal in 2019, Saveo helps traditional pharmacies build a reliable, scalable, and efficient supply chain.

Currently, it is present in Karnataka (covering 70 percent pin code areas), Telangana (covering 35 percent pin codes including Hyderabad) as well as Tamil Nadu (covering 20 percent pin codes). Saveo has over 12,000 active outlets procuring from it and 2,000 empanelled doctors.

Read also: Concord Biotech files IPO papers with SEBI

Tags:    
Article Source : PTI

Disclaimer: This site is primarily intended for healthcare professionals. Any content/information on this website does not replace the advice of medical and/or health professionals and should not be construed as medical/diagnostic advice/endorsement/treatment or prescription. Use of this site is subject to our terms of use, privacy policy, advertisement policy. © 2024 Minerva Medical Treatment Pvt Ltd

Our comments section is governed by our Comments Policy . By posting comments at Medical Dialogues you automatically agree with our Comments Policy , Terms And Conditions and Privacy Policy .

Similar News